{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:24:45Z","timestamp":1794918285656,"version":"4.9.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI144462"],"award-info":[{"award-number":["UM1AI144462"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["AI175489"],"award-info":[{"award-number":["AI175489"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["AI164829"],"award-info":[{"award-number":["AI164829"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA265706"],"award-info":[{"award-number":["CA265706"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["AI125068"],"award-info":[{"award-number":["AI125068"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["CA265706"],"award-info":[{"award-number":["CA265706"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Precise, reversible control of gene expression from self\u2011amplifying RNA (saRNA) remains difficult, limiting the therapeutic flexibility of this otherwise potent platform. Although alphavirus\u2011derived saRNAs encode non\u2011structural proteins that drive RNA replication and offer an intrinsic regulatory point, no existing approach has enabled direct, drug\u2011dependent control of this machinery for high\u2011fidelity modulation of expression. Here we engineer saRNA constructs whose replication is activated by the approved small\u2011molecule drug trimethoprim, using drug\u2011responsive degradation domains fused to individual non\u2011structural proteins to regulate self\u2011amplification. As each replication protein contributes differently to RNA copying, we systematically screened fusion configurations and identified an optimal design combining modified replication proteins with a regulated payload. This construct achieved more than a 10\n                    <jats:sup>4<\/jats:sup>\n                    \u2011fold difference between on and off states with negligible background expression. In mice, oral trimethoprim enabled tunable, reversible and temporally programmed expression patterns. When encoding a human immunodeficiency virus antigen, an escalating trimethoprim regimen enhanced germinal centre responses, a key determinant of antibody affinity maturation. This drug\u2011regulated saRNA platform provides a controllable and clinically compatible strategy for vaccines, immunotherapies and gene therapies.\n                  <\/jats:p>","DOI":"10.1038\/s41551-026-01723-6","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:23:31Z","timestamp":1782206611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Engineering drug-responsive replication machinery for precise control of self-amplifying RNA"],"prefix":"10.1038","author":[{"given":"Parisa","family":"Yousefpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin R.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1507-2184","authenticated-orcid":false,"given":"Jan","family":"Lonzaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7734-0567","authenticated-orcid":false,"given":"Kashif","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ledbetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0409-2454","authenticated-orcid":false,"given":"Mariane B.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hostetler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5088-2389","authenticated-orcid":false,"given":"Ashley A.","family":"Lemnios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2801-8053","authenticated-orcid":false,"given":"Jonathan","family":"Dye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linette","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanaka K.","family":"Remba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"G\u00fcereca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7883-1937","authenticated-orcid":false,"given":"Yuebao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8175-3490","authenticated-orcid":false,"given":"Shengwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5786-0659","authenticated-orcid":false,"given":"Yizhou","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0396-2443","authenticated-orcid":false,"given":"Ron","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-1405","authenticated-orcid":false,"given":"Darrell J.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"1723_CR1","doi-asserted-by":"publisher","first-page":"e1558678","DOI":"10.1080\/2162402X.2018.1558678","volume":"8","author":"A Rothschilds","year":"2019","unstructured":"Rothschilds, A. et al. Order of administration of combination cytokine therapies can decouple toxicity from efficacy in syngeneic mouse tumor models. OncoImmunology 8, e1558678 (2019).","journal-title":"OncoImmunology"},{"key":"1723_CR2","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1158\/1078-0432.CCR-16-2677","volume":"23","author":"DJ Messenheimer","year":"2017","unstructured":"Messenheimer, D. J. et al. Timing of PD-1 blockade is critical to effective combination immunotherapy with anti-OX40. Clin. Cancer Res. 23, 6165\u20136177 (2017).","journal-title":"Clin. Cancer Res."},{"key":"1723_CR3","doi-asserted-by":"publisher","first-page":"eaaw5680","DOI":"10.1126\/scitranslmed.aaw5680","volume":"11","author":"EA Chiocca","year":"2019","unstructured":"Chiocca, E. A. et al. Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: results of a phase 1 trial. Sci. Transl. Med. 11, eaaw5680 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1723_CR4","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1158\/1078-0432.CCR-18-3069","volume":"25","author":"P Zhang","year":"2019","unstructured":"Zhang, P. et al. Phase I trial of inducible caspase 9 T cells in adult stem cell transplant demonstrates massive clonotypic proliferative potential and long-term persistence of transgenic T cells. Clin. Cancer Res. 25, 1749\u20131755 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1723_CR5","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1073\/pnas.0706296105","volume":"105","author":"P Johansen","year":"2008","unstructured":"Johansen, P. et al. Antigen kinetics determines immune reactivity. Proc. Natl Acad. Sci. USA 105, 5189\u20135194 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1723_CR6","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/infdis\/jir615","volume":"204","author":"LR Baden","year":"2011","unstructured":"Baden, L. R. et al. Timing of plasmid cytokine (IL-2\/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects. J. Infect. Dis. 204, 1541\u20131549 (2011).","journal-title":"J. Infect. Dis."},{"key":"1723_CR7","doi-asserted-by":"publisher","first-page":"E6639","DOI":"10.1073\/pnas.1606050113","volume":"113","author":"HH Tam","year":"2016","unstructured":"Tam, H. H. et al. Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination. Proc. Natl Acad. Sci. USA 113, E6639\u2013E6648 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1723_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","volume":"6","author":"JT Bulcha","year":"2021","unstructured":"Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L. & Gao, G. Viral vector platforms within the gene therapy landscape. Signal Transduct. Target. Ther. 6, 53 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1723_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","volume":"28","author":"JL Shirley","year":"2020","unstructured":"Shirley, J. L., de Jong, Y. P., Terhorst, C. & Herzog, R. W. Immune responses to viral gene therapy vectors. Mol. Ther. 28, 709\u2013722 (2020).","journal-title":"Mol. Ther."},{"key":"1723_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"J-H Wang","year":"2024","unstructured":"Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. L. & Gao, G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct. Target. Ther. 9, 78 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1723_CR11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","volume":"11","author":"G Ronzitti","year":"2020","unstructured":"Ronzitti, G., Gross, D.-A. & Mingozzi, F. Human immune responses to adeno-associated virus (AAV) vectors. Front. Immunol. 11, 670 (2020).","journal-title":"Front. Immunol."},{"key":"1723_CR12","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/v13081526","volume":"13","author":"V Poletti","year":"2021","unstructured":"Poletti, V. & Mavilio, F. Designing lentiviral vectors for gene therapy of genetic diseases. Viruses 13, 1526 (2021).","journal-title":"Viruses"},{"key":"1723_CR13","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.ymthe.2022.06.004","volume":"30","author":"DE Sabatino","year":"2022","unstructured":"Sabatino, D. E. et al. Evaluating the state of the science for adeno-associated virus integration: an integrated perspective. Mol. Ther. 30, 2646\u20132663 (2022).","journal-title":"Mol. Ther."},{"key":"1723_CR14","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1038\/sj.mt.6300299","volume":"15","author":"DW Russell","year":"2007","unstructured":"Russell, D. W. AAV vectors, insertional mutagenesis, and cancer. Mol. Ther. 15, 1740\u20131743 (2007).","journal-title":"Mol. Ther."},{"key":"1723_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201800219","volume":"14","author":"A Costello","year":"2019","unstructured":"Costello, A. et al. Leaky expression of the TET-On system hinders control of endogenous miRNA abundance. Biotechnol. J. 14, e1800219 (2019).","journal-title":"Biotechnol. J."},{"key":"1723_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ab.2004.07.011","volume":"334","author":"ML Meyer-Ficca","year":"2004","unstructured":"Meyer-Ficca, M. L. et al. Comparative analysis of inducible expression systems in transient transfection studies. Anal. Biochem. 334, 9\u201319 (2004).","journal-title":"Anal. Biochem."},{"key":"1723_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0304-4165(01)00195-7","volume":"1568","author":"H Mizuguchi","year":"2001","unstructured":"Mizuguchi, H. & Hayakawa, T. Characteristics of adenovirus-mediated tetracycline-controllable expression system. Biochim. Biophys. Acta 1568, 21\u201329 (2001).","journal-title":"Biochim. Biophys. Acta"},{"key":"1723_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41392-021-00645-w","volume":"6","author":"C Zhuo","year":"2021","unstructured":"Zhuo, C. et al. Spatiotemporal control of CRISPR\/Cas9 gene editing. Signal Transduct. Target. Ther. 6, 238 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1723_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1021\/acschembio.7b00657","volume":"13","author":"M Kampmann","year":"2018","unstructured":"Kampmann, M. CRISPRi and CRISPRa screens in mammalian cells for precision biology and medicine. ACS Chem. Biol. 13, 406\u2013416 (2018).","journal-title":"ACS Chem. Biol."},{"key":"1723_CR20","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3389\/fphar.2018.01425","volume":"9","author":"JM Kolos","year":"2018","unstructured":"Kolos, J. M., Voll, A. M., Bauder, M. & Hausch, F. FKBP ligands\u2014where we are and where to go?. Front. Pharmacol. 9, 1425 (2018).","journal-title":"Front. Pharmacol."},{"key":"1723_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ymthe.2005.03.022","volume":"12","author":"S Goverdhana","year":"2005","unstructured":"Goverdhana, S. et al. Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol. Ther. 12, 189\u2013211 (2005).","journal-title":"Mol. Ther."},{"key":"1723_CR22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"1723_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41417-022-00435-8","volume":"30","author":"P Aliahmad","year":"2023","unstructured":"Aliahmad, P., Miyake-Stoner, S. J., Geall, A. J. & Wang, N. S. Next generation self-replicating RNA vectors for vaccines and immunotherapies. Cancer Gene Ther. 30, 785\u2013793 (2023).","journal-title":"Cancer Gene Ther."},{"key":"1723_CR24","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.tibtech.2023.05.007","volume":"41","author":"JDG Comes","year":"2023","unstructured":"Comes, J. D. G., Pijlman, G. P. & Hick, T. A. H. Rise of the RNA machines \u2013 Self-amplification in mRNA vaccine design. Trends Biotechnol. 41, 1417\u20131429 (2023).","journal-title":"Trends Biotechnol."},{"key":"1723_CR25","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41417-022-00499-6","volume":"30","author":"GP Dailey","year":"2023","unstructured":"Dailey, G. P., Crosby, E. J. & Hartman, Z. C. Cancer vaccine strategies using self-replicating RNA viral platforms. Cancer Gene. Ther. 30, 794\u2013802 (2023).","journal-title":"Cancer Gene. Ther."},{"key":"1723_CR26","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/pharmaceutics15030947","volume":"15","author":"K Lundstrom","year":"2023","unstructured":"Lundstrom, K. Application of DNA replicons in gene therapy and vaccine development. Pharmaceutics 15, 947 (2023).","journal-title":"Pharmaceutics"},{"key":"1723_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/vaccines9020097","volume":"9","author":"AK Blakney","year":"2021","unstructured":"Blakney, A. K., Ip, S. & Geall, A. J. An update on self-amplifying mRNA vaccine development. Vaccines 9, 97 (2021).","journal-title":"Vaccines"},{"key":"1723_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","volume":"28","author":"K Bloom","year":"2021","unstructured":"Bloom, K., van den Berg, F. & Arbuthnot, P. Self-amplifying RNA vaccines for infectious diseases. Gene Ther. 28, 117\u2013129 (2021).","journal-title":"Gene Ther."},{"key":"1723_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/pathogens12010138","volume":"12","author":"C Schmidt","year":"2023","unstructured":"Schmidt, C. & Schnierle, B. S. Self-amplifying RNA vaccine candidates: alternative platforms for mRNA vaccine development. Pathogens 12, 138 (2023).","journal-title":"Pathogens"},{"key":"1723_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1517\/14712598.6.2.135","volume":"6","author":"GP Pijlman","year":"2006","unstructured":"Pijlman, G. P., Suhrbier, A. & Khromykh, A. A. Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications. Expert Opin. Biol. Ther. 6, 135\u2013145 (2006).","journal-title":"Expert Opin. Biol. Ther."},{"key":"1723_CR31","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41591-024-02851-9","volume":"30","author":"AR Rappaport","year":"2024","unstructured":"Rappaport, A. R. et al. A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nat. Med. 30, 1013\u20131022 (2024).","journal-title":"Nat. Med."},{"key":"1723_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ymthe.2020.11.002","volume":"29","author":"FL Komdeur","year":"2021","unstructured":"Komdeur, F. L. et al. First-in-human phase I clinical trial of an SFV-based RNA replicon cancer vaccine against HPV-induced cancers. Mol. Ther. 29, 611\u2013625 (2021).","journal-title":"Mol. Ther."},{"key":"1723_CR33","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41417-023-00587-1","volume":"30","author":"MA Morse","year":"2023","unstructured":"Morse, M. A. et al. Clinical trials of self-replicating RNA-based cancer vaccines. Cancer Gene. Ther. 30, 803\u2013811 (2023).","journal-title":"Cancer Gene. Ther."},{"key":"1723_CR34","doi-asserted-by":"publisher","first-page":"TPS2696","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS2696","volume":"42","author":"JJ Luke","year":"2024","unstructured":"Luke, J. J. et al. A phase I trial of intratumoral STX-001: a novel self-replicating mRNA expressing IL-12 alone or with pembrolizumab in advanced solid tumors. J. Clin. Oncol. 42, TPS2696\u2013TPS2696 (2024).","journal-title":"J. Clin. Oncol."},{"key":"1723_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47905-1","volume":"15","author":"NT H\u00d5","year":"2024","unstructured":"H\u1ed3, N. T. et al. Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials. Nat. Commun. 15, 4081 (2024).","journal-title":"Nat. Commun."},{"key":"1723_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S1473-3099(23)00650-3","volume":"24","author":"Y Oda","year":"2024","unstructured":"Oda, Y. et al. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet Infect. Dis. 24, 351\u2013360 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1723_CR37","doi-asserted-by":"publisher","unstructured":"Singh, S. & Mukherjee, T. in At War with the Single Strand 125\u2013135 (Springer Nature, 2025); https:\/\/doi.org\/10.1007\/978-981-96-8122-8_11","DOI":"10.1007\/978-981-96-8122-8_11"},{"key":"1723_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/d41586-023-03859-w","volume":"624","author":"E Dolgin","year":"2023","unstructured":"Dolgin, E. Self-copying RNA vaccine wins first full approval: what\u2019s next?. Nature 624, 236\u2013237 (2023).","journal-title":"Nature"},{"key":"1723_CR39","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/s41591-024-02955-2","volume":"30","author":"A Saraf","year":"2024","unstructured":"Saraf, A. et al. An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2\/3 randomized trial. Nat. Med. 30, 1363\u20131372 (2024).","journal-title":"Nat. Med."},{"key":"1723_CR40","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.ymthe.2020.11.010","volume":"29","author":"SM Cafferty","year":"2021","unstructured":"Cafferty, S. M. et al. In vivo validation of a reversible small molecule-based switch for synthetic self-amplifying mRNA regulation. Mol. Ther. 29, 1164\u20131173 (2021).","journal-title":"Mol. Ther."},{"key":"1723_CR41","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41589-018-0146-9","volume":"14","author":"TE Wagner","year":"2018","unstructured":"Wagner, T. E. et al. Small-molecule-based regulation of RNA-delivered circuits in mammalian cells. Nat. Chem. Biol. 14, 1043\u20131050 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"1723_CR42","doi-asserted-by":"publisher","first-page":"100069","DOI":"10.1016\/j.xpro.2020.100069","volume":"1","author":"P Ramadurgum","year":"2020","unstructured":"Ramadurgum, P. & Hulleman, J. D. Protocol for designing small-molecule-regulated destabilizing domains for in vitro use. STAR Protoc. 1, 100069 (2020).","journal-title":"STAR Protoc."},{"key":"1723_CR43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.cell.2006.07.025","volume":"126","author":"LA Banaszynski","year":"2006","unstructured":"Banaszynski, L. A., Chen, L., Maynard-Smith, L. A., Ooi, A. G. L. & Wandless, T. J. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126, 995\u20131004 (2006).","journal-title":"Cell"},{"key":"1723_CR44","doi-asserted-by":"publisher","first-page":"E10457","DOI":"10.1073\/pnas.1812130115","volume":"115","author":"R Abraham","year":"2018","unstructured":"Abraham, R. et al. ADP-ribosyl\u2013binding and hydrolase activities of the alphavirus nsP3 macrodomain are critical for initiation of virus replication. Proc. Natl Acad. Sci. USA 115, E10457\u2013E10466 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1723_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.virusres.2015.01.016","volume":"206","author":"JL Hyde","year":"2015","unstructured":"Hyde, J. L. et al. The 5\u2032 and 3\u2032 ends of alphavirus RNAs \u2013 Non-coding is not non-functional. Virus Res. 206, 99\u2013107 (2015).","journal-title":"Virus Res."},{"key":"1723_CR46","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1099\/jgv.0.000249","volume":"96","author":"JC Rupp","year":"2015","unstructured":"Rupp, J. C., Sokoloski, K. J., Gebhart, N. N. & Hardy, R. W. Alphavirus RNA synthesis and non-structural protein functions. J. Gen. Virol. 96, 2483\u20132500 (2015).","journal-title":"J. Gen. Virol."},{"key":"1723_CR47","doi-asserted-by":"publisher","first-page":"16534","DOI":"10.1073\/pnas.1210418109","volume":"109","author":"G Shin","year":"2012","unstructured":"Shin, G. et al. Structural and functional insights into alphavirus polyprotein processing and pathogenesis. Proc. Natl Acad. Sci. USA 109, 16534\u201316539 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1723_CR48","doi-asserted-by":"publisher","unstructured":"Law, Y.-S. et al. Interdomain flexibility of chikungunya virus nsP2 helicase-protease differentially influences viral RNA replication and infectivity. J. Virol. https:\/\/doi.org\/10.1128\/jvi.01470-20 (2020).","DOI":"10.1128\/jvi.01470-20"},{"key":"1723_CR49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/v16040503","volume":"16","author":"A Y\u0131ld\u0131z","year":"2024","unstructured":"Y\u0131ld\u0131z, A., R\u0103ileanu, C. & Beissert, T. Trans-amplifying RNA: a journey from alphavirus research to future vaccines. Viruses 16, 503 (2024).","journal-title":"Viruses"},{"key":"1723_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/v10030105","volume":"10","author":"B G\u00f6tte","year":"2018","unstructured":"G\u00f6tte, B., Liu, L. & McInerney, G. M. The enigmatic alphavirus non-structural protein 3 (nsP3) revealing its secrets at last. Viruses 10, 105 (2018).","journal-title":"Viruses"},{"key":"1723_CR51","doi-asserted-by":"publisher","first-page":"41636","DOI":"10.1074\/jbc.M307481200","volume":"278","author":"L Vasiljeva","year":"2003","unstructured":"Vasiljeva, L. et al. Regulation of the sequential processing of Semliki Forest virus replicase polyprotein. J. Biol. Chem. 278, 41636\u201341645 (2003).","journal-title":"J. Biol. Chem."},{"key":"1723_CR52","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1128\/jvi.68.3.1874-1885.1994","volume":"68","author":"Y Shirako","year":"1994","unstructured":"Shirako, Y. & Strauss, J. H. Regulation of Sindbis virus RNA replication: uncleaved P123 and nsP4 function in minus-strand RNA synthesis, whereas cleaved products from P123 are required for efficient plus-strand RNA synthesis. J. Virol. 68, 1874\u20131885 (1994).","journal-title":"J. Virol."},{"key":"1723_CR53","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/nprot.2009.95","volume":"4","author":"M DuPage","year":"2009","unstructured":"DuPage, M., Dooley, A. L. & Jacks, T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat. Protoc. 4, 1064\u20131072 (2009).","journal-title":"Nat. Protoc."},{"key":"1723_CR54","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1021\/acssynbio.8b00166","volume":"8","author":"J Wang","year":"2019","unstructured":"Wang, J., Isaacson, S. A. & Belta, C. Modeling genetic circuit behavior in transiently transfected mammalian cells. ACS Synth. Biol. 8, 697\u2013707 (2019).","journal-title":"ACS Synth. Biol."},{"key":"1723_CR55","doi-asserted-by":"crossref","unstructured":"Wang, J., Isaacson, S. A. & Belta, C. Predictions of genetic circuit behaviors based on modular composition in transiently transfected mammalian cells. In 2018 IEEE Life Sci. Conference 85\u201388 (IEEE, 2018).","DOI":"10.1109\/LSC.2018.8572174"},{"key":"1723_CR56","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1021\/sb500263b","volume":"4","author":"N Davidsohn","year":"2015","unstructured":"Davidsohn, N. et al. Accurate predictions of genetic circuit behavior from part characterization and modular composition. ACS Synth. Biol. 4, 673\u2013681 (2015).","journal-title":"ACS Synth. Biol."},{"key":"1723_CR57","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/biom10050695","volume":"10","author":"JH Lautaoja","year":"2020","unstructured":"Lautaoja, J. H. et al. Differentiation of murine C2C12 myoblasts strongly reduces the effects of myostatin on intracellular signaling. Biomolecules 10, 695 (2020).","journal-title":"Biomolecules"},{"key":"1723_CR58","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1074\/mcp.M400182-MCP200","volume":"4","author":"T Kislinger","year":"2005","unstructured":"Kislinger, T. et al. Proteome dynamics during C2C12 myoblast differentiation. Mol. Cell. Proteomics 4, 887\u2013901 (2005).","journal-title":"Mol. Cell. Proteomics"},{"key":"1723_CR59","doi-asserted-by":"publisher","unstructured":"Broderick, K. E. & Humeau, L. M. in Enhanced Delivery of DNA or RNA Vaccines by Electroporation 193\u2013200 (Springer, 2017); https:\/\/doi.org\/10.1007\/978-1-4939-6481-9_12","DOI":"10.1007\/978-1-4939-6481-9_12"},{"key":"1723_CR60","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817\u2013838 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1723_CR61","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1056\/NEJM199512073332308","volume":"333","author":"HM Blau","year":"1995","unstructured":"Blau, H. M. & Springer, M. L. Muscle-mediated gene therapy. N. Engl. J. Med. 333, 1554\u20131556 (1995).","journal-title":"N. Engl. J. Med."},{"key":"1723_CR62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/sj.gt.3301874","volume":"10","author":"QL Lu","year":"2003","unstructured":"Lu, Q. L., Bou-Gharios, G. & Partridge, T. A. Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther. 10, 131\u2013142 (2003).","journal-title":"Gene Ther."},{"key":"1723_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adl3755","volume":"9","author":"SH Bhagchandani","year":"2024","unstructured":"Bhagchandani, S. H. et al. Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response. Sci. Immunol. 9, eadl3755 (2024).","journal-title":"Sci. Immunol."},{"key":"1723_CR64","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.immuni.2007.07.009","volume":"27","author":"CDC Allen","year":"2007","unstructured":"Allen, C. D. C., Okada, T. & Cyster, J. G. Germinal-center organization and cellular dynamics. Immunity 27, 190\u2013202 (2007).","journal-title":"Immunity"},{"key":"1723_CR65","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","volume":"30","author":"GD Victora","year":"2012","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 30, 429\u2013457 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"1723_CR66","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature13300","volume":"509","author":"AD Gitlin","year":"2014","unstructured":"Gitlin, A. D., Shulman, Z. & Nussenzweig, M. C. Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature 509, 637\u2013640 (2014).","journal-title":"Nature"},{"key":"1723_CR67","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41586-020-3036-8","volume":"589","author":"R Jones","year":"2021","unstructured":"Jones, R., Bragagnolo, G., Arranz, R. & Reguera, J. Capping pores of alphavirus nsP1 gate membranous viral replication factories. Nature 589, 615\u2013619 (2021).","journal-title":"Nature"},{"key":"1723_CR68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2213934120","volume":"120","author":"R Jones","year":"2023","unstructured":"Jones, R. et al. Structural basis and dynamics of Chikungunya alphavirus RNA capping by nsP1 capping pores. Proc. Natl Acad. Sci. USA 120, e2213934120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1723_CR69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/v10020071","volume":"10","author":"FA Bakar","year":"2018","unstructured":"Bakar, F. A. & Ng, L. F. P. Nonstructural proteins of alphavirus\u2014potential targets for drug development. Viruses 10, 71 (2018).","journal-title":"Viruses"},{"key":"1723_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51952-z","volume":"15","author":"V Kril","year":"2024","unstructured":"Kril, V. et al. Alphavirus nsP3 organizes into tubular scaffolds essential for infection and the cytoplasmic granule architecture. Nat. Commun. 15, 8106 (2024).","journal-title":"Nat. Commun."},{"key":"1723_CR71","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.virusres.2017.01.007","volume":"234","author":"MK Pietil\u00e4","year":"2017","unstructured":"Pietil\u00e4, M. K., Hellstr\u00f6m, K. & Ahola, T. Alphavirus polymerase and RNA replication. Virus Res. 234, 44\u201357 (2017).","journal-title":"Virus Res."},{"key":"1723_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add2536","volume":"8","author":"YB Tan","year":"2022","unstructured":"Tan, Y. B. et al. Molecular architecture of the chikungunya virus replication complex. Sci. Adv. 8, eadd2536 (2022).","journal-title":"Sci. Adv."},{"key":"1723_CR73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.omtm.2019.08.002","volume":"15","author":"H Peng","year":"2019","unstructured":"Peng, H. et al. Non-antibiotic small-molecule regulation of DHFR-based destabilizing domains in vivo. Mol. Ther. Methods Clin. Dev. 15, 27\u201339 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1723_CR74","doi-asserted-by":"crossref","unstructured":"Wroblewska, L. et al. Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery. Nat. Biotechnol. 33, 839\u2013841 (2015).","DOI":"10.1038\/nbt.3301"},{"key":"1723_CR75","doi-asserted-by":"publisher","first-page":"8099","DOI":"10.1021\/acs.nanolett.5b03528","volume":"15","author":"B Li","year":"2015","unstructured":"Li, B. et al. An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo. Nano Lett. 15, 8099\u20138107 (2015).","journal-title":"Nano Lett."},{"key":"1723_CR76","doi-asserted-by":"publisher","first-page":"171","DOI":"10.32614\/RJ-2019-003","volume":"11","author":"H An","year":"2019","unstructured":"An, H., Landis, J. T., Bailey, A. G., Marron, J. S. & Dittmer, D. P. dr4pl: a stable convergence algorithm for the 4 parameter logistic model. R J. 11, 171 (2019).","journal-title":"R J."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01723-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01723-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01723-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:23:39Z","timestamp":1782206619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01723-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":76,"alternative-id":["1723"],"URL":"https:\/\/doi.org\/10.1038\/s41551-026-01723-6","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.Y., J.L., Y.L., R.W. and D.J.I. are inventors on a patent filed by MIT related to this work (patent no. 12139721). D.J.I. and R.W. are co-founders and equity holders in Strand Therapeutics. Y.D. is an inventor on a patent filed by The Ohio State University related to the TT3 lipid used in this work (patent no. PCT\/US2016\/033514). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}